Taiwan · Delayed Price · Currency is TWD Ligand Pharmaceuticals Statistics
Total Valuation
TPEX:4401 has a market cap or net worth of TWD 1.93 billion. The enterprise value is 3.62 billion.
| Market Cap | 1.93B |
| Enterprise Value | 3.62B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Jul 30, 2025 |
Share Statistics
TPEX:4401 has 122.69 million shares outstanding.
| Current Share Class | 122.69M |
| Shares Outstanding | 122.69M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.66% |
| Owned by Institutions (%) | 0.79% |
| Float | 82.06M |
Valuation Ratios
The trailing PE ratio is 14.92.
| PE Ratio | 14.92 |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | 9.38 |
| P/OCF Ratio | 4.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.78, with an EV/FCF ratio of 17.63.
| EV / Earnings | 28.04 |
| EV / Sales | 0.90 |
| EV / EBITDA | 7.78 |
| EV / EBIT | 25.63 |
| EV / FCF | 17.63 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.91.
| Current Ratio | 1.22 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 5.39 |
| Debt / FCF | 12.27 |
| Interest Coverage | 3.48 |
Financial Efficiency
Return on equity (ROE) is 4.84% and return on invested capital (ROIC) is 1.68%.
| Return on Equity (ROE) | 4.84% |
| Return on Assets (ROA) | 1.53% |
| Return on Invested Capital (ROIC) | 1.68% |
| Return on Capital Employed (ROCE) | 3.85% |
| Revenue Per Employee | 5.03M |
| Profits Per Employee | 161,962 |
| Employee Count | 797 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.93 |
Taxes
In the past 12 months, TPEX:4401 has paid 32.14 million in taxes.
| Income Tax | 32.14M |
| Effective Tax Rate | 19.52% |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 0.46, so TPEX:4401's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 16.34 |
| 200-Day Moving Average | 19.40 |
| Relative Strength Index (RSI) | 41.75 |
| Average Volume (20 Days) | 53,903 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4401 had revenue of TWD 4.01 billion and earned 129.08 million in profits. Earnings per share was 1.05.
| Revenue | 4.01B |
| Gross Profit | 353.85M |
| Operating Income | 143.40M |
| Pretax Income | 164.65M |
| Net Income | 129.08M |
| EBITDA | 453.49M |
| EBIT | 143.40M |
| Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 881.91 million in cash and 2.52 billion in debt, giving a net cash position of -1.64 billion or -13.35 per share.
| Cash & Cash Equivalents | 881.91M |
| Total Debt | 2.52B |
| Net Cash | -1.64B |
| Net Cash Per Share | -13.35 |
| Equity (Book Value) | 2.77B |
| Book Value Per Share | 22.17 |
| Working Capital | 474.71M |
Cash Flow
In the last 12 months, operating cash flow was 470.98 million and capital expenditures -265.66 million, giving a free cash flow of 205.32 million.
| Operating Cash Flow | 470.98M |
| Capital Expenditures | -265.66M |
| Free Cash Flow | 205.32M |
| FCF Per Share | 1.67 |
Margins
Gross margin is 8.82%, with operating and profit margins of 3.57% and 3.22%.
| Gross Margin | 8.82% |
| Operating Margin | 3.57% |
| Pretax Margin | 4.10% |
| Profit Margin | 3.22% |
| EBITDA Margin | 11.30% |
| EBIT Margin | 3.57% |
| FCF Margin | 5.12% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 4.49%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 4.49% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 47.52% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.49% |
| Earnings Yield | 6.70% |
| FCF Yield | 10.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 26, 2022. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 26, 2022 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
TPEX:4401 has an Altman Z-Score of 1.72 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | 7 |